Answers are grounded in this paper and cite their sources.
Background: Ameloblastoma is a neoplastic odontogenic tumor that has a local invasive characteristic. The current treatment for ameloblastoma requires a precise surgical resection and chemotherapy. It requires a different approach to diminish the therapy drawbacks. Curcumin, as one of the most common well-described compounds, remarkably has a potential antitumor agent. Method: Our findings and opinions are based on a comprehensive search through scientific resources and correspondingly relating all the keywords using the Boolean technique and Medical Subject Headings (MeSH) term search to find the interest study. Review: By understanding curcumin and its target genes, curcumin itself can induce regulation of tumor suppression and oncogenic microRNA. MiR-9 has proven to be expressed for modulating the mutation genes causing tumorogenesis in ameloblastoma. Curcumin also upregulates miR-9, causing cytotoxic activity against cancers in many proven studies. Conclusion: The highly expressed miR-9 curcumin-mediated ameloblastoma inhibition will be the new insight and adjunct cancer therapy.
No takes yet. Share an insight, caveat, or question.
Hanif et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: